SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 6

Giant hepatic hemangioma treatment with transcatheter arterial embolisation and transcatheter arterial chemoembolisation; Comparative results

Hakkı Timur SİNDEL
Özhan ÖZGÜR
Pages
29432950–29432950
Publication Date
2022-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, TACE causes greater volume reduction with less pain and, therefore, is the better endovascular treatment option.Key words: Liver, hemangioma, angiography, bleomycin, embolization

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Treatment of hepatic hemangiomas is a controversial topic, and traditional treatment is surgical excision.
📊
Key Findings & Data:Materials and methods: A total of 104 patients underwent TACE using bleomycin, and 108 patients underwent TAE.
💡
Conclusion & Impact:However, TACE causes greater volume reduction with less pain and, therefore, is the better endovascular treatment option.Key words: Liver, hemangioma, angiography, bleomycin, embolization
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Treatment of hepatic hemangiomas is a controversial topic, and traditional treatment is surgical excision. Transcatheter arterial embolisation (TAE) and transcatheter arterial chemoembolisation (TACE) have been reported as minimally invasive treatment methods. To the best of our knowledge, there are no studies comparing use of TACE and TAE for hepatic hemangioma treatment. The aim of the study is to compare symptom resolution, size reducing effects, and complications of TACE and TAE for the treatment of giant hepatic hemangiomas. Materials and methods: A total of 104 patients underwent TACE using bleomycin, and 108 patients underwent TAE. The patients were followed-up for 2 year and follow-up images at 6 months, 12 months, and 24 months were acquired. Lesion volumes in both follow-up images were calculated. The patients were examined for any possible procedure related complications as well as the status of their initial symptoms. Results: The shrinkage period was determined to have ended after 12. month in both groups. The results of the two-way mixed ANOVA showed that there was significant main effect of procedure type (p ≤ 0.001) on hemangioma volumes. Similarly, there was a significant interaction between procedure and time (p ≤ 0.001). Conclusion: Both methods are effective in symptomatic relief in properly selected patients. However, TACE causes greater volume reduction with less pain and, therefore, is the better endovascular treatment option.Key words: Liver, hemangioma, angiography, bleomycin, embolization

🔖

Cite This Article

SİNDEL, H. T., ÖZGÜR, Ö. (2022). Giant hepatic hemangioma treatment with transcatheter arterial embolisation and transcatheter arterial chemoembolisation; Comparative results. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 6, 29432950–29432950. https://ajindex.com/articles/609510

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Giavroglou C, Economou H, Ioannidis I, Hirano A, Kimura T et al. Arterial embolization of giant hepatic hemangiomas. CardioVascular and Interventional Radiology 2003
  2. doi: 10.1007/s00270-002-2648-8 2. Bozkaya H, Cinar C, Besir FH, Parildar M, Oran I. Minimally invasive treatment of giant haemangiomas of the liver: embolisation with bleomycin. CardioVascular and Interventional Radiology 2014
  3. doi: 10.1007/ s00270-013-0618-y 3. Toro A, Mahfouz AE, Ardiri A, Malaguarnera M, Malaguarnera G et al. What is changing in indications and treatment of hepatic hemangiomas. A review. Annals of Hepatology 2014
  4. doi: 10.1016/S1665-2681(19)30839-7 4. Srivastava DN, Gandhi D, Seith A, Pande GK, Sahni P. Transcatheter arterial embolization in the treatment of symptomatic cavernous hemangiomas of the liver: a prospective study. Abdominal Imaging 2001
  5. doi: 10.1007/s00261- 001-0007-x 5. Farges O, Daradkeh S, Bismuth H. Cavernous hemangiomas of the liver: Are there any indications for resection? World Journal of Surgery 1995
  6. 19–24. doi: 10.1007/BF00316974 6. Belli L, De Carlis L, Beati C, Rondinara G, Sansalone V. Surgical treatment of symptomatic giant hemangiomas of the liver. Surgery, Gynecology and Obstetrics, USA: John Mark Ockerbloom
  7. pp. 474-478. 7. Duxbury MS, Garden OJ. Giant haemangioma of the liver: observation or resection? Digestive Surgery 2010
  8. doi: 10.1159/000268108 8. Yedibela S, Alibek S, Müller V, Aydin U, Langheinrichet M et al. Management of hemangioma of the liver: surgical therapy or observation? World Journal of Surgery 2013
  9. doi: 10.1007/s00268-013-1904-1 9. Schnelldorfer T, Ware AL, Smoot R, Schleck CD, Harmsen WS, et al. Management of giant hemangioma of the liver: resection versus observation. American College of Surgeons 2010
  10. doi: 10.1016/j.jamcollsurg.2010.08.006 10. Li Y, Jia Y, Li S, Wang W, Wang Z et al. Transarterial Chemoembolization of Giant Liver Haemangioma: A Multicenter Study with 836 Cases. Cell Biochemistry and Biophysics 2015
  11. doi: 10.1007/s12013-015-0680-y 11. Sun JH, Nie CH, Zhang YL, Zhou GH, Ai J et al. Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma. PLoS One 2015
  12. e0135158. doi: 10.1371/journal. pone.0135158 12. Zeng Q, Li Y, Chen Y, Ouyang Y, He X et al. Gigantic cavernous hemangioma of the liver treated by intra-arterial embolization with pingyangmycin-lipiodol emulsion: a multi-cente